This is what has me scratching my head. They have $2.6m cash in the bank and access to a further $2m from NAB. So, what is it that would require potentially more than $4.6m? This is where my head goes:
- They were approached by someone (institutional investor, large Cannabis company, who knows) looking to take a stake in the company and are willing to pay a premium for the shares which would still work out cheaper than if they had to buy on market
- Something has happened and the company hasn't been forthcoming with investors but needs to shore up capital ASAP - I strongly doubt this is the case as I received an email from Nan last week saying the crops were doing very well
- NAB is looking to remove or decrease the facility due to other bad loans in the industry *cough* CAN *cough*
- There is an opportunity that exceeds their current cash reserves and facilities
- We will never find out, the company will issue the standard discount and say something stupid like "for general working capital"
- Forums
- ASX - By Stock
- ECS
- Ann: Trading Halt
Ann: Trading Halt, page-10
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECS (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $20.61M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $17.55K | 1.051M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1193399 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 1978464 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1193399 | 0.016 |
4 | 2050000 | 0.015 |
9 | 2482499 | 0.014 |
7 | 1498274 | 0.013 |
5 | 1050000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 1978464 | 4 |
0.018 | 1385266 | 6 |
0.019 | 975000 | 4 |
0.020 | 620000 | 3 |
0.021 | 283106 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ECS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online